
Sign up to save your podcasts
Or


Former executives from Valent Pharmaceuticals appear to be under investigation. Shares of Tronc fall 20% after Gannett walks away from its bid. Jim Gillies and Bill Barker discuss those stories, plus how Bath & Body Works is driving results for L Brands, and how scented candles are part of the plan. Chris Hill shares highlights (and lowlights) from the Marine Corps Marathon.
By The Motley Fool4.7
16041,604 ratings
Former executives from Valent Pharmaceuticals appear to be under investigation. Shares of Tronc fall 20% after Gannett walks away from its bid. Jim Gillies and Bill Barker discuss those stories, plus how Bath & Body Works is driving results for L Brands, and how scented candles are part of the plan. Chris Hill shares highlights (and lowlights) from the Marine Corps Marathon.

3,221 Listeners

1,488 Listeners

807 Listeners

948 Listeners

523 Listeners

1,166 Listeners

2,182 Listeners

825 Listeners

1,422 Listeners

1,037 Listeners

9,717 Listeners

196 Listeners

826 Listeners

87 Listeners

585 Listeners

1,036 Listeners

53 Listeners